(Q44253511)
Statements
1 reference
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up (English)
1 reference
Stein Kaasa
1 reference
Stein Sundstrøm
1 reference
Roy M Bremnes
1 reference
Ulf Aasebø
1 reference
Reidulv Hatlevoll
1 reference
Ragnar Dahle
1 reference
Nils Boye
1 reference
Mari Wang
1 reference
Tor Vigander
1 reference
Jan Vilsvik
1 reference
Eva Skovlund
1 reference
Einar Hannisdal
1 reference
Steinar Aamdal
1 reference
Norwegian Lung Cancer Study Group
1 reference
1 December 2002
1 reference
1 reference
20
1 reference
24
1 reference
4665-4672
1 reference
Identifiers
1 reference
1 reference